proteas
pro
sever
acut
respiratori
syndrom
coronaviru
sarscov
play
key
role
viral
replic
attract
target
antisar
drug
discoveri
report
fluoresc
reson
energi
transfer
fret
base
method
develop
assess
proteolyt
activ
sarscov
pro
two
intern
quench
fluorogen
peptid
correspond
ntermin
ctermin
autocleavag
site
sarscov
pro
respect
use
substrat
sarscov
pro
seem
work
effici
transcleavag
assay
mutat
analysi
demonstr
residu
ntermin
amino
acid
domain
iii
sarscov
pro
import
enzymat
activ
antibodi
recogn
domain
iii
could
significantli
inhibit
enzymat
activ
sarscov
pro
effect
classspecif
proteas
inhibitor
transcleavag
activ
reveal
enzym
work
like
serin
proteas
rather
papain
proteas
proteolyt
process
viral
polyprotein
key
step
replic
cycl
mani
positivestrand
rna
virus
process
sever
acut
respiratori
syndrom
coronaviru
sarscov
perform
papainlik
proteas
proteas
pro
crystal
structur
sarscov
pro
recent
resolv
two
group
reveal
great
similar
structur
pro
porcin
transmiss
gastroenter
viru
tgev
human
coronaviru
strain
form
dimer
monom
enzym
contain
three
structur
domain
first
two
domain
form
chymotrypsin
fold
contain
catalyt
site
compris
third
domain
globular
ahel
structur
link
domain
ii
long
loop
extra
helic
domain
iii
uniqu
coronaviru
pro
picornaviru
proteas
contain
chymotrypsin
fold
extra
domain
role
domain
iii
sarscov
pro
quit
clear
seem
involv
dimer
format
due
function
import
sarscov
pro
becom
attract
target
structurebas
drug
design
sar
fulfil
need
effici
robust
highthroughput
screen
antiproteas
drug
conveni
assay
system
measur
enzymat
activ
need
studi
establish
fluoresc
reson
energi
transfer
fret
base
method
assess
proteolyt
activ
pro
two
intern
quench
fluorogen
iqf
peptid
nterminu
conjug
orthoaminobenzo
acid
abz
cterminu
conjug
lysdnp
synthes
use
substrat
upon
cleavag
substrat
fluorophor
separ
quench
group
gener
fluoresc
signal
enzymat
reaction
monitor
real
time
use
fretbas
method
character
enzymat
activ
catalyt
sitemut
pro
nterminusdelet
pro
domain
iiidelet
pro
diii
also
use
system
demonstr
proteas
inhibitor
monoclon
antibodi
recogn
domain
iii
inhibitori
effect
proteolyt
activ
pro
fretbas
real
time
assay
provid
ideal
platform
explor
inhibitor
sarscov
pro
conveni
system
studi
kinet
proteolyt
reaction
construct
pro
cdna
correspond
sarscov
strain
nt
code
pro
protein
amplifi
pcr
revers
transcript
mixtur
provid
dr
pj
chen
graduat
institut
clinic
medicin
nation
taiwan
univers
taipei
taiwan
pcr
product
clone
vector
novagen
result
plasmid
design
pro
verifi
sequenc
express
purif
pro
protein
plasmid
transform
escherichia
coli
cell
grown
reach
induc
express
recombin
protein
mm
iptg
h
cell
harvest
disrupt
buffer
mm
trishcl
ph
mm
nacl
mm
imidazol
cell
lysat
appli
nickel
affin
column
amersham
pharmacia
biotech
ab
uppsala
sweden
wash
pro
protein
elut
linear
gradient
buffer
b
mm
trishcl
ph
mm
nacl
mm
imidazol
buffer
fraction
contain
pro
pool
dialyz
storag
buffer
mm
trishcl
ph
mm
nacl
mm
edta
sampl
concentr
store
storag
buffer
contain
glycerol
protein
pure
assess
sdspage
delet
point
mutat
use
pro
templat
three
mutant
clone
diii
gener
oneprim
pcr
method
describ
previous
singl
primer
use
substitut
alanin
primer
cagcaaatgggtcgggatcccttcccgtcaggcaaagttg
use
delet
ntermin
amino
acid
pro
primer
gcaggtacagacacaaccatagcgg
use
delet
ctermin
amino
acid
pro
mutant
clone
verifi
sequenc
proteas
activ
assay
use
iqf
peptid
substrat
two
synthet
iqf
peptid
abzthrseralavalleuglnflserglyphearglysdnp
abzserglyvalthrpheglnflglylysphelyslysdnp
genem
synthesi
south
san
francisco
ca
use
studi
fl
indic
cleavag
site
reaction
mixtur
contain
mm
hepe
ph
mm
dtt
mm
nacl
triton
lm
peptid
substrat
lm
pro
reaction
perform
black
microtit
plate
incub
enzym
ad
increas
fluoresc
record
continu
use
labsystem
fluoromet
fluoroskan
ascent
plate
reader
accessori
excit
emiss
wavelength
nm
respect
kinet
paramet
determin
lineweaverburk
plot
use
lm
enzym
lm
peptid
substrat
analysi
peptid
cleavag
hplc
cleavag
assay
carri
reaction
mixtur
describ
h
stop
addit
formic
acid
reaction
product
resolv
c
analyt
column
mm
mm
beckman
fullerton
ca
use
linear
gradient
acetonitril
trifluoroacet
acid
ml
min
flow
rate
elut
monitor
absorb
wavelength
nm
inhibit
assay
inhibitori
activ
proteas
inhibitor
antibodi
toward
pro
measur
reaction
mixtur
lack
dtt
presenc
variou
concentr
lm
inhibitor
differ
amount
antiserum
monoclon
antibodi
ascit
two
cystein
proteas
inhibitor
nethylmaleimid
nem
two
serin
proteas
inhibitor
naptosylllysin
chloromethyl
keton
tlck
nptosyllphenylalanin
chloromethyl
keton
tpck
sigma
use
studi
antibodi
use
rabbit
antisarscov
pro
antiserum
three
mous
pro
monoclon
antibodi
unpublish
data
establish
fretbas
assay
wildtyp
sarscov
pro
first
express
e
coli
purifi
nearli
homogen
fig
meanwhil
three
mutant
protein
pro
substitut
ala
delet
ntermin
amino
acid
residu
delet
domain
iii
aa
diii
express
well
assess
role
residu
domain
proteolyt
activ
sarscov
pro
due
extra
sequenc
deriv
fulllength
sarscov
pro
express
kda
protein
contain
tag
nterminu
cterminu
howev
realiz
ctermin
sequenc
sarscov
pro
vtfq
connect
amino
acid
residu
vector
aaalehhhhhh
could
actual
form
consensu
cut
site
sarscov
pro
vtfqflaaa
result
protein
would
kda
instead
kda
fig
thu
result
clearli
suggest
sarscov
pro
express
possess
ciscleavag
activ
contrari
three
mutant
protein
appar
possess
proteolyt
activ
size
anticip
ie
kda
kda
kda
diii
pro
mutant
protein
recogn
rabbit
antisarscov
pro
antiserum
fig
howev
diii
recogn
mous
antisarscov
pro
monoclon
antibodi
mab
fig
suggest
monoclon
antibodi
might
recogn
epitop
resid
domain
iii
two
iqf
peptid
use
vitro
transcleavag
assay
sequenc
correspond
ntermin
ctermin
autocleavag
site
sarscov
pro
respect
enzymat
activ
sarscov
pro
toward
analyz
direct
monitor
increas
fluoresc
real
time
fig
parallel
cleav
product
obtain
reaction
analyz
reversephas
hplc
fig
fretbas
hplcbase
assay
indic
wildtyp
sarscov
pro
better
cleavag
effici
accord
hplc
data
cleav
sarscov
pro
h
wherea
cleav
fig
kinet
paramet
calcul
base
fretbas
assay
k
valu
lm
k
cat
min
k
cat
k
mm
min
k
lm
k
cat
min
k
cat
k
mm
min
contrari
three
mutant
extrem
low
proteolyt
activ
peptid
substrat
measur
fretbas
assay
fig
result
indic
ntermin
amino
acid
domain
iii
import
catalyt
residu
proteolyt
activ
sarscov
pro
inhibitori
effect
proteas
inhibitor
sarscov
pro
sarscov
pro
belong
cystein
proteas
famili
chymotrypsin
fold
thu
interest
know
whether
inhibit
serin
proteas
inhibitor
cystein
proteas
inhibitor
inhibitori
effect
two
serin
proteas
inhibitor
tlck
tpck
two
cystein
proteas
inhibitor
nem
test
fretbas
assay
data
shown
fig
demonstr
serin
proteas
inhibitor
reduc
enzymat
activ
sarscov
pro
dosedepend
manner
howev
result
two
cystein
proteas
inhibitor
inconsist
nem
signific
inhibitori
effect
sarscov
pro
inhibit
data
support
idea
sarscov
pro
work
follow
gener
base
mechan
like
serin
proteas
follow
thiolateimidazolium
ion
pair
catalyt
mechan
like
papain
proteas
howev
nem
probabl
inhibit
proteolyt
activ
sarscov
pro
via
directli
block
catalyt
residu
due
abil
bind
stoichiometr
sulfhydryl
sh
group
cystein
cystein
proteas
famili
previous
gener
three
monoclon
antibodi
mab
mab
mab
could
recogn
fulllength
sarscov
pro
protein
lack
domain
iii
fig
data
shown
interpret
monoclon
antibodi
probabl
recogn
epitop
resid
domain
iii
therefor
interest
test
whether
could
inhibit
proteolyt
activ
sarscov
pro
transcleavag
assay
rabbit
antisarscov
pro
polyclon
antiserum
also
test
data
shown
fig
reveal
three
monoclon
antibodi
could
inhibit
enzymat
activ
wherea
polyclon
antiserum
inhibitori
activ
knowledg
first
report
demonstr
enzymat
activ
sarscov
pro
could
inhibit
antibodi
result
confirm
pivot
role
domain
iii
proteolyt
activ
sarscov
pro
summari
fretbas
method
detect
proteolyt
activ
sarscov
pro
evalu
studi
kinet
studi
show
ntermin
autocleavag
site
sarscov
pro
better
substrat
ctermin
autocleavag
site
fig
effect
proteas
inhibitor
activ
sarscov
pro
two
serin
proteas
inhibitor
tlck
tpck
two
cystein
proteas
inhibitor
nem
rang
lm
ad
reaction
mixtur
contain
substrat
fluoresc
monitor
continu
data
shown
mean
sd
fluoresc
intens
reaction
transcleavag
assay
recent
fan
et
al
systemat
analyz
substrat
specif
sarscov
pro
found
posit
substrat
requir
larg
hydrophob
residu
hydrophob
interact
posit
pocket
enzym
indic
crystal
structur
although
phe
val
met
toler
sarscov
pro
mutat
hydrophob
residu
decreas
reaction
activ
sinc
leu
posit
phe
may
explain
cleav
less
effici
sarscov
pro
delet
data
fig
antibodi
block
data
fig
indic
ntermin
amino
acid
domain
iii
import
enzymat
activ
sarscov
pro
similar
conclus
also
reach
pro
tgev
previou
crystal
structur
data
attribut
import
dimer
function
mediat
two
domain
howev
recent
studi
chen
et
al
report
ntermin
seven
amino
acid
sarscov
pro
requir
enzym
dimer
instead
propos
nterminusdelet
mutant
conform
reduc
size
bind
pocket
thu
creat
unfavor
condit
substrat
bind
discrep
role
ntermin
seven
amino
acid
residu
complet
resolv
moment
need
investig
differ
analyt
method
howev
matter
function
ntermin
domain
may
play
definit
import
proteolyt
activ
sarscov
pro
demonstr
activ
assay
fig
effect
antibodi
activ
sarscov
pro
differ
amount
mous
antisarscov
pro
monoclon
antibodi
mab
mab
mab
rabbit
antisarscov
pro
polyclon
antiserum
pab
ad
proteolyt
reaction
mixtur
contain
substrat
fluoresc
monitor
continu
data
shown
fluoresc
intens
reaction
